Combination of IMP3 and PCNA Expression in Diagnosis of Laryngeal Squamous Cell Carcinoma

Document Type : Original Article

Authors

1 Pathology Department, Faculty of Medicine, Sohag university

2 Faculty of Medicine, Pathology Department, Sohag University

3 Otorhinolaryngology department, sohag faculty of medicine, sohag university, sohag, Egypt

4 Department of pathology, Faculty of Medicine, Sohag University.

Abstract

ABSTRACT

Background: Laryngeal carcinoma is one of the most common head and neck cancer worldwide. It has a high mortality rate and poor prognosis. Insulin-like growth factor II m-RNA-binding protein 3 (IMP3) is one of IMP family members which plays an important role in cell growth and migration during embryogenesis and has a role in carcinogenesis. Proliferating Cell Nuclear Antigen (PCNA) is a nuclear protein that is considered as a cell proliferation marker and has an important role in DNA duplication. Aim of the work: This study aimed to evaluate IMP3 and PCNA expression in laryngeal squamous cell carcinoma (LSCC), carcinoma in situ (CIS) and hyperplastic lesions. Patients and methods: Fifty cases of LSCC plus 8 cases of CIS and 9 cases of hyperplastic lesions were stained with IMP3 and PCNA and its immunoexpression results were statistically evaluated. Results: There is a significant positive correlation between IMP3 and PCNA expression in LSCC (p < 0.001 and r= 0.860) which indicates that IMP3 synchronously acts with PCNA to promote uncontrolled cell growth and proliferation. Conclusions: Combined use of IMP3 and PCNA increases the sensitivity and specificity of diagnosis of LSCC.

Key words: Immunohistochemical expression IMP3, PCNA, laryngeal squamous cell carcinoma.

Keywords

Main Subjects

Sohag Medical Journal
Volume 29, Issue 3
Clinical Science Volume
2025
Pages 143-155

Files

Share

How to cite

Statistics